Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (5y) (2015 - 2026)
Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,134.00 |
| Dec 31, 2025 | 20,705.00 |
| Sep 30, 2025 | 18,023.00 |
| Jun 30, 2025 | -38,240.00 |
| Mar 31, 2025 | 21,546.00 |
| Dec 31, 2024 | -585,929.00 |
| Dec 31, 2023 | -573,536.00 |
| Jun 30, 2023 | 219,667.00 |
| Mar 31, 2023 | 239,332.00 |
| Dec 31, 2022 | 23,946.00 |
| Sep 30, 2022 | -21,444.00 |
| Jun 30, 2022 | -11,792.00 |
| Mar 31, 2022 | 21,272.00 |
| Dec 31, 2021 | -35,223.00 |
| Sep 30, 2021 | 4.12 Mn |
| Jun 30, 2021 | 4.79 Mn |
| Mar 31, 2021 | 3.47 Mn |
| Dec 31, 2020 | 4.91 Mn |
| Sep 30, 2020 | 2.92 Mn |
| Jun 30, 2020 | 573,146.00 |